Refine
Document Type
- Article (8)
- Contribution to a Periodical (1)
Has Fulltext
- yes (9)
Is part of the Bibliography
- no (9)
Keywords
- Angiogenesis (1)
- CVID (1)
- European Society for Immunodeficiencies (ESID) (1)
- Experimental models of disease (1)
- German PID-NET registry (1)
- HIPPO signalling (1)
- HMGB1 (1)
- IgG substitution therapy (1)
- Metabolism (1)
- PID prevalence (1)
Institute
Systemic treatment is necessary for one third of patients with renal cell carcinoma. No valid biomarker is currently available to tailor personalized therapy. In this study we established a representative panel of patient derived xenograft (PDX) mouse models from patients with renal cell carcinomas and determined serum levels of high mobility group B1 (HMGB1) protein under treatment with sunitinib, pazopanib, sorafenib, axitinib, temsirolimus and bevacizumab. Serum HMGB1 levels were significantly higher in a subset of the PDX collection, which exhibited slower tumor growth during subsequent passages than tumors with low HMGB1 serum levels. Pre-treatment PDX serum HMGB1 levels also correlated with response to systemic treatment: PDX models with high HMGB1 levels predicted response to bevacizumab. Taken together, we provide for the first time evidence that the damage associated molecular pattern biomarker HMGB1 can predict response to systemic treatment with bevacizumab. Our data support the future evaluation of HMGB1 as a predictive biomarker for bevacizumab sensitivity in patients with renal cell carcinoma.
Shape complementarity is a compulsory condition for molecular recognition. In our 3D ligand-based virtual screening approach called SQUIRREL, we combine shape-based rigid body alignment with fuzzy pharmacophore scoring. Retrospective validation studies demonstrate the superiority of methods which combine both shape and pharmacophore information on the family of peroxisome proliferator-activated receptors (PPARs). We demonstrate the real-life applicability of SQUIRREL by a prospective virtual screening study, where a potent PPARalpha agonist with an EC50 of 44 nM and 100-fold selectivity against PPARgamma has been identified...
Spherical harmonics coeffcients for ligand-based virtual screening of cyclooxygenase inhibitors
(2011)
Background: Molecular descriptors are essential for many applications in computational chemistry, such as ligand-based similarity searching. Spherical harmonics have previously been suggested as comprehensive descriptors of molecular structure and properties. We investigate a spherical harmonics descriptor for shape-based virtual screening. Methodology/Principal Findings: We introduce and validate a partially rotation-invariant three-dimensional molecular shape descriptor based on the norm of spherical harmonics expansion coefficients. Using this molecular representation, we parameterize molecular surfaces, i.e., isosurfaces of spatial molecular property distributions. We validate the shape descriptor in a comprehensive retrospective virtual screening experiment. In a prospective study, we virtually screen a large compound library for cyclooxygenase inhibitors, using a self-organizing map as a pre-filter and the shape descriptor for candidate prioritization. Conclusions/Significance: 12 compounds were tested in vitro for direct enzyme inhibition and in a whole blood assay. Active compounds containing a triazole scaffold were identified as direct cyclooxygenase-1 inhibitors. This outcome corroborates the usefulness of spherical harmonics for representation of molecular shape in virtual screening of large compound collections. The combination of pharmacophore and shape-based filtering of screening candidates proved to be a straightforward approach to finding novel bioactive chemotypes with minimal experimental effort.
Microangiopathy with subsequent organ damage represents a major complication in several diseases. The mechanisms leading to microvascular occlusion include von Willebrand factor (VWF), notably the formation of ultra-large von Willebrand factor fibers (ULVWFs) and platelet aggregation. To date, the contribution of erythrocytes to vascular occlusion is incompletely clarified. We investigated the platelet-independent interaction between stressed erythrocytes and ULVWFs and its consequences for microcirculation and organ function under dynamic conditions. In response to shear stress, erythrocytes interacted strongly with VWF to initiate the formation of ULVWF/erythrocyte aggregates via the binding of Annexin V to the VWF A1 domain. VWF-erythrocyte adhesion was attenuated by heparin and the VWF-specific protease ADAMTS13. In an in vivo model of renal ischemia/reperfusion injury, erythrocytes adhered to capillaries of wild-type but not VWF-deficient mice and later resulted in less renal damage. In vivo imaging in mice confirmed the adhesion of stressed erythrocytes to the vessel wall. Moreover, enhanced eryptosis rates and increased VWF binding were detected in blood samples from patients with chronic renal failure. Our study demonstrates that stressed erythrocytes have a pronounced binding affinity to ULVWFs. The discovered mechanisms suggest that erythrocytes are essential for the pathogenesis of microangiopathies and renal damage by actively binding to ULVWFs.
Les recherches ethnologiques effectuées jusqu'à ce jour se sont concentrées principalement sur deux grands axes. Elles ont d'une part dressé un inventaire détaillé des forges et de leurs techniques dans les différents groupes ethniques de cette région. D'autre part, elles ont examiné l'histoire des migrations et de la sédentarisation des forgerons. Il serait intéressant de savoir si les résultats des recherches linguistiques concordent avec ceux des travaux d'ethnologie. Jusqu'ici, les recherches ont montré la mobilité des forgerons professionnels. Ces "travailleurs transfrontaliers" de la culture jouent le rôle de médiateurs et favorisent les échanges culturels à l'intérieur de chaque ethnie et entre les différentes ethnies. En raison de cette mobilité, l'inventaire et les produits des forges présentent souvent des caractères identiques, même sur des espaces géographiques de plus grande taille. Par contre, le vocabulaire est souvent influencé par des mots empruntés à d'autres langues. Ce phénomène constituera précisément un des éléments centraux dans la suite de nos recherches sur le thème des artisans.
Die EU verabschiedete am 21. Mai 1992 die Richtlinie zur Erhaltung der natürlichen Lebensräume sowie der wildlebenden Tiere und Pflanzen, die sogenannte Fauna-Flora-Habitat-Richtlinie (FFH-Richtlinie). Die Mitgliedsstaaten sind seitdem verpflichtet, ein europaweites Netz von besonderen Schutzgebieten zur Erhaltung der biologischen Vielfalt und zur Förderung einer nachhaltigen Entwicklung aufzubauen. In dieses Natura 2000 genannte Netz sind auch die auf der Grundlage der seit 1979 geltenden EU-Vogelschutzrichtlinie gemeldeten Europäischen Vogelschutzgebiete (EU SPA) integriert. Die reichhaltige Naturausstattung Sachsen-Anhalts ermöglichte die Auswahl von 265 FFH-Gebieten und 32 Vogelschutzgebieten (EU SPA). Die Gebiete wurden als „Gebiete von gemeinschaftlicher Bedeutung der kontinentalen und der atlantischen biogeographischen Region“ im Amtsblatt der EU vom 15.01.2008 veröffentlicht. Nach den Vorgaben der FFH- und Vogelschutzrichtlinie sind die Natura 2000-Gebiete nun als besondere Schutzgebiete national zu sichern. Darüber hinaus sind in den besonderen Schutzgebieten geeignete Maßnahmen zu treffen, um die Verschlechterung der natürlichen Lebensräume und der Habitate der Arten, für die die Gebiete ausgewiesen worden sind, zu vermeiden (vgl. Art. 6, Abs. 2 FFH Richtlinie). Alle erforderlichen Maßnahmen sind an den Ansprüchen der in den jeweiligen Gebieten vorkommenden Lebensraumtypen und Arten auszurichten.
Mit dem vorliegenden Sonderheft wird beispielhaft der Verfahrensweg der Ausweisung des Naturschutzgebietes Aland-Elbe-Niederung zur Umsetzung von Natura 2000 im Land Sachsen-Anhalt dokumentiert. Neben der Darstellung der naturräumlichen Situation des Gebietes und seiner naturschutzfachlichen Bedeutung werden insbes. Inhalt und Ablauf des Verwaltungsverfahrens sowie die Lösung der vielfältigen Nutzungskonflikte dargestellt. Dem Heft liegt eine beidseitig bedruckte Schutzgebietskarte des Landes Sachsen-Anhalt im Maßstab 1:250.000 bei. Auf einer Seite sind Schutzgebiete nach internationalem Recht dargestellt. Die zweite Seite der Karte liefert eine aktuelle Zusammenstellung (Stand 31.12.2009) der nach Landesnaturschutzrecht geschützten Gebiete und Objekte. Ein Beiheft mit Namen, Bezeichnung und Größe aller Gebiete komplettiert die Ausgabe.
Angiogenesis, the process by which endothelial cells (ECs) form new blood vessels from existing ones, is intimately linked to the tissue’s metabolic milieu and often occurs at nutrient-deficient sites. However, ECs rely on sufficient metabolic resources to support growth and proliferation. How endothelial nutrient acquisition and usage are regulated is unknown. Here we show that these processes are instructed by Yes-associated protein 1 (YAP)/WW domain-containing transcription regulator 1 (WWTR1/TAZ)-transcriptional enhanced associate domain (TEAD): a transcriptional module whose function is highly responsive to changes in the tissue environment. ECs lacking YAP/TAZ or their transcriptional partners, TEAD1, 2 and 4 fail to divide, resulting in stunted vascular growth in mice. Conversely, activation of TAZ, the more abundant paralogue in ECs, boosts proliferation, leading to vascular hyperplasia. We find that YAP/TAZ promote angiogenesis by fuelling nutrient-dependent mTORC1 signalling. By orchestrating the transcription of a repertoire of cell-surface transporters, including the large neutral amino acid transporter SLC7A5, YAP/TAZ-TEAD stimulate the import of amino acids and other essential nutrients, thereby enabling mTORC1 activation. Dissociating mTORC1 from these nutrient inputs—elicited by the loss of Rag GTPases—inhibits mTORC1 activity and prevents YAP/TAZ-dependent vascular growth. Together, these findings define a pivotal role for YAP/TAZ-TEAD in controlling endothelial mTORC1 and illustrate the essentiality of coordinated nutrient fluxes in the vasculature.
Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs.
Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel.
Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1–25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36% of patients. Familial cases were observed in 21% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0–88 years). Presenting symptoms comprised infections (74%) and immune dysregulation (22%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE- syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49% of all patients received immunoglobulin G (IgG) substitution (70%—subcutaneous; 29%—intravenous; 1%—unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy.
Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment.